---
schema_version: "secwatch.filing_event.v1"
accession: "0001437402-26-000043"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2026-08-06T20:09:56+00:00"
generated_at: "2026-08-06T20:13:15.055408+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ardelyx Q2 revenue up 31% to $118.1M; cuts FY2026 IBSRELA guidance to $350-370M

## Summary
- Q2 total product revenue $118.1M (+31% YoY); IBSRELA $86.2M (+33%), XPHOZAH $31.9M (+27%).
- Net loss $16.7M ($0.07/sh) vs $19.1M ($0.08) prior year; cash $281.8M.
- FY2026 IBSRELA guidance revised to $350-370M; XPHOZAH reiterated $110-120M; OPEX below $500M.
- Long-term IBSRELA $1B target remains but timing uncertain; XPHOZAH long-term guidance pulled.
- Drew $50M from SLR facility; CMS lawsuit dismissed, not appealing.

## SEC filing metadata
- accession: 0001437402-26-000043
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2026-08-06T20:09:56+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000043/0001437402-26-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000143740226000043/ardx-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437402-26-000043
- JSON: https://secwatch.observer/filing/0001437402-26-000043.json
- Plain text: https://secwatch.observer/filing/0001437402-26-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.